Low Utilization Of Nuclear Scintigraphy For Cardiac Amyloidosis Evaluation Among Patients With Aortic Stenosis Referred For Transcatheter Aortic Valve Replacement
Due to high prevalence of ATTR cardiomyopathy among patients referred for transcatheter aortic valve replacement (TAVR), routine screening using nuclear scintigraphy with bone-avid radiotracers has been recommended in this population. Real-world adoption of these recommendations, however, is variable and is incompletely characterized, especially at programs in non-North American or European countries. Accordingly, we aimed to describe the utilization of Tc-99m pyrophosphate (PYP) scintigraphy in patients undergoing TAVR at a tertiary referral center in the Middle East.
Source: Journal of Cardiac Failure - Category: Cardiology Authors: Shaikha Alketbi, Merna Hassan, Sarada Medeti, Mouaz Oudih, Anas El Zouhbi, Yosef Manla, Firas Al Badarin Tags: 162 Source Type: research
More News: Amyloidosis | Aortic Stenosis | Cardiology | Cardiomyopathy | Heart | Heart Valve Surgery | Middle East Health | USA Health